A t t e n d A s i a ’s F i r st


                                                    Compliance &
                       ...
COMPLIANCE AND FINAN
Conference Connection is pleased to announce the inaugural                           WHO SHOULD ATTEN...
NCIAL REPORTING: KEY MARKET TREND
                                                                                        ...
DS AND EMERGING ISSUES
CE AGENDA
    Friday, 30th May 2008

    9.00am     Conference Chairman's Opening                  ...
CFRP 2008
                                     OUR DISTINGUISHED PANEL OF SPEAKERS
              Fatimah Moideen Kutty is ...
5 E ASY WAY S T O R E G IS T ER
     Conference Connection Administrators Pte Ltd            Singapore             Singapo...
Upcoming SlideShare
Loading in...5
×

Compliance

1,180

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
1,180
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
13
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Compliance

  1. 1. A t t e n d A s i a ’s F i r st Compliance & Financial Reporting for the PHARMACEUTICAL & BIOTECHNOLOGY Key Issues To Be Addressed • Current Challenges in Financial Reporting • Valuing Pharmaceutical Intangibles industries in ASIA PACIFIC 2008 • Accounting for Share Based Payments 29th – 30th May, 2008 • Marina Mandarin Hotel • Singapore • Best Practices in Strategic Deals and Collaborations • New Regulations on Sales and Marketing Reporting Conference Co-Chairmen Circula Compliance • Mr Mark Stehr, Partner, Deloitte Financial t CFO, Ce to: VP Fin • Tax and Transfer Pricing Advisory Services LLP, USA Accou ontro , Strategy Issues • Mr Peter Coleman, Principal, Head – Tax D ntant , Treller, • The Changing CFO Role Forensic Services, Singapore and Southeast Asia, Deloitte & Touche Reg. Air., Compliaasurer, • A Risk Centric Internal Financial Advisory Pte Ltd, Singapore Audito ff. Dir., Int nce & r, Gen e . Counrnal Audit Model • Anti-Fraud Programs and Distinguished Panel of Experts sel . Controls • Ms M K Fatimah, Head of Pharmacy Department, • Securities and Shareholder Alexandra Hospital, Member of Consumer Education Liability Risk Issues Committee, Consumer Association of Singapore (CASE), Singapore • Latest Developments in • Mr Mukesh Butani, Partner, BMR & Associates, India China and India • Mr George Lin, Head of Non-Japan Asia Healthcare Investment Banking, • IFRS as a Strategic Credit Suisse (Hong Kong) Limited, Hong Kong Opportunity • Mr Philip Chong, Director, Enterprise Risk Services, Deloitte & Touche, Singapore • Mr Rajan Ekambaram, Partner, Ernst & Young, Singapore Pre-Conference Workshop on Individually • Ms Aruno Rajaratnam, Managing Director, Willis Asia, Singapore Priced and Managing Bookable • Mr Aman Kumar, Manager, Business Performance Services, KPMG Separately Advisory Services Pte Ltd, Singapore and Protecting • Mr Derek Berry, Business Leader, Human Capital – ASEAN, Mercer, Intellectual Singapore • Mr Chris McNamara, Asia Pacific Controller, Merck & Co., Inc., Singapore Property Produces • Ms Lay Peng Tan, Financial Controller, Pfizer Worldwide Pharmaceutical Bottom-Line Operations, Singapore Benefits • Mr Lee Chian Yorn, Partner, PricewaterhouseCoopers, Singapore by Mr Mark Stehr, Partner, Forensic • Mr Lars Barslev, Partner, Vanden Advisors 0! & Dispute Services, Deloitte VE $20 Financial Advisory Services (FAS) LLP, Singapore irds SA arch, 2008. LLP, USA • Ms Audrey Yap, Managing Partner, Early B by 28 M etails Regi ster for d Yu Sarn Audrey & Partners, Singapore k page c 1.00pm – 5.30pm, 28 May 2008 - see ba
  2. 2. COMPLIANCE AND FINAN Conference Connection is pleased to announce the inaugural WHO SHOULD ATTEND Compliance and Financial Reporting for Pharmaceutical & Biotechnology Industries in Asia Pacific 2008 (CFRP 2008) Vice Presidents of Finance • CFOs • Chief Accounting will be held in Singapore from 29-30 May 2008. This conference Officers • Controllers and Accountants • Treasurers • is the first of its kind in Asia! Tax Directors • Compliance Directors • Internal Auditors CFRP 2008 addresses key and pressing issues such as the regional • Accounting and Risk Managers • Investor Relations impact of the new rules by the US on Sales and Marketing Reporting • General Counsel • Regulatory Affairs Directors Compliance, the trend toward International Financial Reporting Standards (IFRS), the changing role of the CFO and more. Do not miss this rare opportunity to be a part of this exclusive gathering ABOUT THE ORGANIZERS of key financial executives. Our select group of experts will provide Conference Connection Administrators Pte you with the latest market trends, business expertise and technical Ltd is dedicated to the provision of global business updates. Register NOW to book your seats! information through high profile, premier-sector focused business events, including international KEY BENEFITS conferences, corporate events and symposia, for the With all the recent changes in rules and regulations, there has oil & gas industries and other business sectors never been a more critical time to examine the most pressing internationally. Dedicated to providing an accounting and financial reporting issues. Gain a complete independent platform for interaction and discussion understanding of these issues and benefit your organization by registering TODAY!! of the latest business & industry strategies, it strives to combine excellence and professionalism through You want to be at this conference to: linkage with inter-governmental, professional and • Learn about key financial issues in the pharmaceutical industry • Evaluate the strategic opportunity of IFRS industry groups worldwide. The Group has an • Increase your knowledge of sales and marketing reporting extensive track record of successful events and since compliance its inception in 1994, has held more than 1500 events • Be updated on the latest developments in China and India days, attended by 15,000 participants from over 50 • Review the changing role of the CFO countries. For a full list of courses, conferences and • Enhance your understanding of transfer pricing issues in the industry other activities e-mail: info@cconnection.org or • Review best practices in strategic deals and collaborations visit our website at www.cconnection.org. • Gain insights into industry practices in judgmental areas of financial reporting • Stay current on industry specific accounting and financial SPONSORSHIP OPPORTUNITIES reporting issues Please e-mail info@cconnection.org for a sponsorship • Acquire information on market practices, trends and focus kit and full information on sponsorship opportunities. • Evaluate the challenges and outlook for the future Thank you for your interest! Individually Priced and Bookable Half-Day Optional Pre-Conference Workshop Separately Managing and Protecting Intellectual Property for Bottom Line Benefits Workshop Leader: Mr Mark Stehr, Partner, Deloitte Financial Advisory Services LLP, USA 28 May 2008, 1.00pm – 5.30pm, Marina Mandarin Hotel, Singapore Intellectual asset management in today’s life sciences industry is often fragmented and inconsistent. However, those organisations that ABOUT YOUR WORKSHOP actively protect, manage and market their IP assets can improve profit margins, shareholder value and competitive positioning. Intellectual LEADER property is like mercury; it’s changeable and takes many forms. As a Mark Stehr is a partner in the Forensic & consequence, life sciences companies often struggle to define and Dispute Services practice of Deloitte Financial effectively manage their intellectual assets. Effective IP management Advisory Services (FAS) LLP and has 22 years is crucial to the bottom line of companies of all sizes because it impacts of experience in the public accounting revenue growth and market share. profession. The half-day workshop will: • Include case studies from the United States, Europe and Asia Mark has conducted numerous investigations on behalf of • Focus in IP Protection issues specific to the Health & Life Sciences industry sector pharmaceutical, medical device and technology clients in • Discuss what types of IP require what levels of protections matters relating to improper expenditures, revenue leakage • Some simple techniques that companies can implement to assist and whistleblower allegations. in protection of their IP • How sharing IP can be a way to create and launch new products, Mark also has led many international investigations, including increase market share and improve your competitive position • Help you identify IP within your organisation that you currently in Asia/Pacific, Europe and South America, where he has don’t recognise identified hundreds of millions of dollars in lost revenues • Increase the value of R&D spending on underutilised IP resulting from a variety of circumstances, including financial • The basics of an IP investigation fraud, misreporting by alliance partners, product diversion, The cost is US$600 per person plus 10% discount if you wish to counterfeit/gray goods schemes and simple mistakes. attend both the conference and workshop. Workshop is individually priced with joint attendance discounts. Please visit www.cconnection.org for full details. Vi s i t www. cconne ct i on. or g
  3. 3. NCIAL REPORTING: KEY MARKET TREND CONFERENC Thursday, 29th May 2008 8.00am Registration and Morning Coffee 2.10pm Investment Opportunities in Healthcare in Greater China in the 8.50am Conference Chairman's Welcome Near-Term Future Address and Opening Remarks • Overview of healthcare landscape in Greater Critical accounting issues as they relate to current China business climate will be addressed. In particular, • Recent stock performance of listed healthcare newest issues in the pharmaceutical, companies in China biotechnology and life sciences industries and • Survey of recent healthcare IPO's and M&A's their impact on future business plans will be in Greater China highlighted. • Comparison with select US and Asia companies in healthcare 9.10am Valuing Intangibles and Impairment • Comparison with India healthcare landscape Testing in the Pharmaceutical Industry • Near term trends in medical devices, services • Approaches for valuing intangible assets in an and biopharmaceuticals in Greater China acquisition Mr George Lin, Head of Non-Japan Asia • Approaches to subsequent impairment tests, Healthcare Investment Banking, Credit Suisse both for goodwill and other intangibles (Hong Kong) Limited, Hong Kong Mr Lars Barslev, Partner, Vanden Advisors LLP, Singapore 3.00pm Being the Best – Insights from Leading Finance Functions • Key differentiators of leading finance functions 9.55am Accounting for Share Based Payments - can these be replicated in other organizations? and Other Compensation Issues • Balancing the demands of the internal business • Share Based Payment Valuations with external stakeholders and regulatory bodies • Implications for Long Term Incentive (LTI) • How to overcome barriers to achieving leading Design practices • Perfecting your LTIs • What does a future finance department look like? • Governance and Regulatory Impact on Executive Compensation Mr Aman Kumar, Manager, Business Performance Services, KPMG Advisory Services Pte Ltd, Singapore • Key Executive Compensation Trends Mr Derek Berry, Business Leader - Human Capital, 3.45pm Coffee Break ASEAN, Mercer, Singapore 4.05pm IFRS – Its Development, Implication and 10.40am Coffee Break Impact on the Pharmaceutical Industry • How global financial markets are driving the 11.10am Case Study: Understanding India trend toward IFRS • SEC vote to remove reconciliation requirement Speaker to be advised • Implication of trend toward IFRS on pharmaceutical industry 12.00pm Best Practices in Strategic Deals and • Significant differences about financial reporting Collaborations and disclosure requirements • Understanding the rationale for deals & • What is actually involved in conversion collaborations Mr Lee Chian Yorn, Partner, • Negotiating strategic deals PricewaterhouseCoopers, Singapore • Types of Deals- License agreements, Joint Ventures, Acquisitions 4.50pm Transfer Pricing Issues in the • Contractual terms and considerations Pharmaceutical Industry • Due diligence process • Industry Trends Ms Audrey Yap, Managing Partner, Yu Sarn • Developing strong internal controls for Transfer Audrey & Partners, Singapore Pricing • What NOT to share in the TP report 12.45pm Lunch • Practical issues/strategies Mr Mukesh Butani, Partner, BMR & Associates, India 5.35pm Close of Day One Copyright © Conference Connection Administrators Pte.Ltd. The organiz To register, call +65 6222 0230 or fax +65 6222 0121 or email info@cconnection.org
  4. 4. DS AND EMERGING ISSUES CE AGENDA Friday, 30th May 2008 9.00am Conference Chairman's Opening 2.00pm New Regulations in Sales and Marketing Remarks Reporting Compliance • Interactions with healthcare professionals - Events including foreign travel 9.05am The Changing CFO Role: From Keeping - Sponsorship the Score to Shaping the Play - Hospitality • Key drivers to the changing role - Entertainment • Shift in focus: Financial Control Systems, Risk - Gifts and promotional items Management, Regulatory Compliance, • Responsibilities of pharmaceutical-healthcare Financial Analysis and Reporting, Development professionals-patient relationship of Corporate Strategy, Performance • Transparency of promotion Management Systems • Standards of promotional information • Investments in business support technology • Disguised and misleading promotion solutions to achieve business goals • Compliance programme development • Transparency and communication with • Risk assessment investors Mr Chris McNamara, Asia Pacific Controller, • Balancing the changing demands and Merek & Co., Inc, Singapore maintaining performance standards Ms Lay Peng Tan, Financial Controller, Pfizer 2.45pm Forum on Sales and Marketing Worldwide Pharmaceutical Operations, Singapore Reporting Compliance: Healthcare - Pharma - Patient Associations 9.50am A Risk Centric Internal Audit Model Mr Mark Stehr, Partner, Deloitte Financial • Effectiveness of assurance from risk Advisory Services Pte Ltd, USA management in addition to internal controls Mr Chris McNamara, Asia Pacific Controller, Mr Rajan Ekambaram, Partner, Ernst & Young, Merck & Co., Inc., Singapore Singapore Are patients paying more than necessary for their drugs? 10.35am Coffee Break Ms M K Fatimah, Head of Pharmacy Department, 11.00am Protecting Pharmaceutical Companies Alexandra Hospital, Member of Consumer against Fraud and Misconduct Risks Education Committee, Consumer Association of Singapore (CASE), Singapore • Benefits and elements of an effective anti-fraud program and other panelists from Healthcare and Patient • Fraud and misconduct risk assessments Associations to be advised • Fraud schemes common to the pharmaceutical industry 3.15pm Coffee Break Mr Mark Stehr, Partner, Deloitte Financial 3.40pm Using Compliance Management to Advisory Services Pte Ltd, USA Overcome Financial and Reputation Mr Peter Coleman, Principal, Head - Forensic Risks in the Pharma Industry Services, Singapore and Southeast Asia, Deloitte • Challenges in complying to multiple regulations & Touche Financial Advisory Services Pte Ltd, - increasing complexity and costs Singapore • Elements of a sustainable compliance framework to maintain brand value • How to implement a cost-effective and 11.45am Securities and Shareholder Liability sustainable compliance regime Risk Issues • Use of compliance technologies • Obligations and good practices • How to mitigate securities and shareholder Mr Philip Chong, Director, Enterprise Risk Services, litigation risks Deloitte & Touche, Singapore • Insurance and indemnity to protect co- officers/directors from personal liability 4.25pm Looking Ahead: Outlook and Challenges for the Future Ms Aruno Rajaratnam, Managing Director, Willis (All speakers and delegates are invited) Asia, Singapore 4.55pm Chairman's Closing Remarks 12.30pm Lunch 5.00pm End of Conference zers reserve the right to alter the content and timing of the programme. Vi si t www. cconne ct i on. or g
  5. 5. CFRP 2008 OUR DISTINGUISHED PANEL OF SPEAKERS Fatimah Moideen Kutty is the Chief Pharmacist of Insurance Institute of United Kingdom in 1984. Aruno has extensive Pharmacy Department at the Alexandra Hospital and industry experience having worked as a claims manager, underwriter, a Member of Consumer Education Committee in loss adjuster, product development consultant, broker and managing Consumer Association of Singapore (CASE) and also the director of a reinsurance company. Vice President of the Pharmaceutical Society of Singapore (PSS). Fatimah had also worked in the Pharmacy Practice Aman Kumar is a Manager with the Business Unit in the National Pharmaceutical Administration in Performance Services practice in KPMG Singapore. He the Ministry of Health (MOH) and in National University specialises in the field of business performance Hospital before. She is most passionate about re-designing processes improvement, cost management and control, business to ensure a hassle free system, especially in the area of Medication performance management, strategic sourcing, change Safety and Patient Education. As part of joint collaboration between management and process analysis and redesign. Aman PSS and CASE, Fatimah worked on the project of educating consumers started his career with KPMG as an audit senior in the on how to reduce their drug cost and healthcare cost in 2007. external audit field, and is a trained and qualified accountant. Since moving into the field of business advisory services, Mukesh Butani is a founder partner of BMR & Associates, he has been involved in advising both private and public sector a leading professional services Firm with competencies organizations on a variety of business issues. His country experience in tax services. Mukesh is the Tax Practice leader of the includes Singapore and India. Firm and specializes in corporate International Tax and Transfer Pricing matters. He has over 24 years' experience Derek Berry is the Head of Human Capital for the in advising several fortune 500 multinationals on a range ASEAN countries in Mercer. He was previously responsible of cross-border tax structuring, transfer pricing, mergers for leadership of the Sydney consulting team and been & acquisitions and inbound investment structuring matters. a practice leader for executive compensation. Derek has He is an acknowledged expert in the area of transfer pricing and cross- won and project managed a range of large consulting border tax matters and has authored a treatise on Transfer Pricing for projects including competency frameworks, executive LexisNexis Butterworths. For consecutive years, Butani has been compensation, organization change, innovative consistently rated amongst leading individual tax advisors in India. classification and reward projects, culture assessment and performance management. A number of projects have required George Lin is the Head of Non-Japan Asia Healthcare international co-ordination. Derek's recent client engagements have Investment Banking based in Credit Suisse (Hong Kong) included major Singaporean, Australian and international companies. Limited. George has many years of investment banking experience with expertise in M&A and securities offerings. Christopher McNamara is the Controller in Asia Pacific Recently, George has worked on numerous transactions, - Finance Support for Merck & Co., Inc., responsible for including the IPO of WuXi Pharmatech on the NYSE, sales & marketing and manufacturing operations in the the acquisition of FISH assets for China Medical, the sale Asia Pacific Region. As Controller his responsibilities of Tanox to Genentech for $919M USD and the sale of include the development of regional strategies, Chiron to Novartis for over $5B USD. George has also worked on operational plans, investment plans and monitoring numerous financings for Amgen, China Medical, Cell Genesys, Ariad operational results, ensuring clarity on associated and Agria. In Hong Kong, George is also co-head of the NJA Consumer risks/opportunities. The responsibilities require a strong & Retail Investment Banking. emphasis on robust governance structure surrounding the control environment. Philip Chong is the Director of Deloitte’s Enterprise Risk Services, leading the Risk & Governance practice. This Lay Peng Tan is the Financial Controller and the Head practice comprises of 70 professionals and provides enterprise of Department (Finance) of Pfizer Worldwide risk management and IT governance services. In recent Pharmaceutical Operations, where she is responsible years, Philip led a number of leading edge business and for operations, financial planning and analysis. IT risk management consultancy projects in Singapore and the region. These projects range from the design and development of governance frameworks, risk management frameworks and enterprise value models. He has been personally involved in 20 enterprise risk and governance projects. He is currently leading an Lee Chian Yorn is an Advisory Partner with R&D initiative to design and implement a technology enabling solution PricewaterhouseCoopers (PwC), with over 14 years of for Governance, Risk Management & Compliance. The technology named experience in public accounting, including two and half Risk Integrator provides a repository of controls and a technology-enabled years in PwC US where he was seconded. Chian Yorn process to implement a sustainable compliance framework. currently leads PwC's Global Capital Markets and Accounting Advisory group, which provides advice on capital markets, Peter Coleman is Principal with Deloitte Singapore accounting for M&A transactions and other complex and is the leader of the Deloitte Forensic practice in accounting topics to our audit and non-audit clients. The Singapore and Southeast Asia. Previously Peter was a Group also specialises in US GAAP/IFRS matters, and provides assistance partner of Aegis International Fraud & Security Consulting to clients in accessing the U.S. and other overseas capital markets. He (USA & Australia) for three years and prior to that, Vice also has extensive experience in working with a diverse base of public President Asia Pacific with Praesidium Services Limited and multinational companies based in Singapore and US. (UK). Peter was also an Associate Director in the Fraud and Dispute division of PwC. Peter has also owned and Lars Barslev is a Partner with Vanden Advisors LLP. Lars operated his own corporate fraud investigation agency in Australia, has more than 12 years of business experience in the worked for international organisations in the ASEAN region and was area of Financial Advisory Services. He was a Senior a detective with the Victoria Police in Australia for many years. Manager with the Valuation & Strategy practice at PricewaterhouseCoopers in Denmark and Singapore. Rajan Ekambaram is a Partner of Business Risk Services Subsequently, he was an Associate Director heading the in Ernst & Young Singapore. Rajan has over eighteen Valuation & M&A team at KPMG Corporate Finance in years of experience in both external and internal audits Singapore. His regional experience spans across Cambodia, in Singapore, India and many other Asian countries. He Hong Kong, Indonesia, Laos, Malaysia, Thailand, and Vietnam. has served clients in a wide range of industries including trading, retailing, hotels, manufacturing, hi-tech, Audrey Yap [LLM; LLB; Registered Patent Agent construction and quasi-governmental organizations. (Singapore); Advocate & Solicitor (Singapore); Advocate Rajan had been overseeing the internal audit outsourcing & Solicitor (Malaysia); Solicitor (England & Wales)] is a engagements of many Public-listed companies based in Singapore founding partner of the law firm Yu Sarn Audrey & Partners and also the Asian operations of a number of multi-national clients. and heads the IP Department of her firm. Audrey served He has also been involved in conducting internal audit and risk as an Examiner for the Singapore Patent Agents Qualifying management training sessions for client and internal staff. Examinations from 2002 to 2006. She was the Singapore representative to the Designs Committee of the Asian Aruno Rajaratnam is the Managing Director of Willis Patent Attorneys Association from 1998 to 2004. Audrey is an Adjunct Asia, FINEX Division. She is responsible for the Fellow of the IP Academy and was appointed Regional Consultant by development, marketing and placement of FINEX products the World IP Organisation (WIPO) for a project conducted in ASEAN in Asia. She was admitted as an Advocate & Solicitor of from 2004-2005 in the use of IP as an economic tool for growth. the Singapore Bar in February 1975. She is also a Chartered Insurance Practitioner conferred by the Chartered To register, call +65 6222 0230 or fax +65 6222 0121 or email info@cconnection.org
  6. 6. 5 E ASY WAY S T O R E G IS T ER Conference Connection Administrators Pte Ltd Singapore Singapore info@cconnection.org www.cconnection.org MAIL 105 Cecil Street, #07-02 The Octagon, S(069534) PHONE (65) 6222 0230 FAX (65) 6222 0121 EMAIL ONLINE DATES & VENUE ENQUIRIES & REGISTRATIONS be levied an administrative fee of 5% for Wednesday – Friday, 28 – 30 May 2008, Conference Connection Administrators Pte Ltd, paid cancellations and 10% for unpaid Singapore 105 Cecil Street, #07-02 The Octagon, cancellations. Marina Mandarin Singapore, Singapore 069534. • Paid and unpaid cancellations notified and 6 Raffles Boulevard, Marina Square, Tel: (65) 6222 0230 acknowledged between 8 - 15 May 2008 Singapore 039594 Fax: (65) 6222 0121 will be given a 50% refund and one set of Tel: (65) 6845 1000 Email: info@cconnection.org the conference documentation (post event). Fax: (65) 6845 1001 Website: www.cconnection.org • No refund will be given after 15 May 2008 Website: www.marina-mandarin.com.sg but delegates can be substituted if the REGISTRATION CONDITIONS organizers receive prior notification (please REGISTRATION FEES FOR CFRP 2008 • All registrations must be on the prescribed note that 2 weeks prior notice of • Full Fee: US$1,895 per person form or in writing and will be on a confirmed substitution is required for visa application/ • Early Bird: US$1,695 per person (pay by basis unless otherwise notified in writing. cancellation as the case may be). 28 March 2008) • The organizers reserve the right not to • For registrations invoiced and unpaid but • Team Fee: US$1,695 per person for the accept prior and on-site registrations subsequently cancelled after 15 May 2008, second and subsequent delegate from the without payment. Delegates whose 50% the invoiced fees will be charged and same company and billing address. payments are not received before the event one set of conference documentation will are required to furnish proof of payment be given (post event). REGISTRATION FEES FOR WORKSHOP on-site. • Full Fee: US$600 per person • Staff at the event will request a credit card HOTEL ACCOMMODATION & VISA • Team/ Joint Attendance Fee: US$540 per guarantee without proof of prior payment. APPLICATION person for the second and subsequent • The organizers reserve the right to impose Delegates will be responsible for their own delegate from the same company OR for conditions of entry for walk-in delegates. hotel and visa arrangements. Special rates delegates also attending CFRP 2008. have been secured at the Marina Mandarin PAYMENTS Hotel for confirmed delegates. To take Registration fees include attendance at all • All payments are to be made in advance advantage of the special rate, please request sessions, daily luncheon, coffee breaks and of the conference in US Dollars by Inter- for a hotel reservation form upon registration. one set of conference documentation per Bank transfers. (Bank details will be person. Travel, accommodation and visa costs provided upon receipt of registration). DISCLAIMER are not included. • Please quote event name, invoice number The organizers will not accept liability for non-approval and delegate name for bank transfers. of visas, individual transport delays and transport MAXIMUM FLEXIBILITY Please instruct your bank to remit the full disruption, and in such circumstances, our normal amount, net of bank charges. cancellation rules and penalties apply. Where matters Companies may nominate different beyond the reasonable control of the organizers impair participants to attend the Workshop and still or prevent the organizers from being able to perform benefit from the Joint Attendance discount. CANCELLATION & SUBSTITUTION POLICY their obligation under this event, the client releases the • Cancellations notified in writing by letter organizers from any liability, incidental or consequential, and acknowledged before 8 May 2008 will to such matters. CFRP 2008 REGISTRATION FORM Please PRINT in block letters and return to: Conference Connection Administrators Pte Ltd 105 Cecil Street, #07-02 The Octagon, Singapore 069534. Tel: (65) 6222 0230 Fax: (65) 6222 0121 Email: info@cconnection.org Website:www.cconnection.org ❐ Yes! Please register me: (For more than one delegate, please photocopy the registration form) First Name (Mr/Ms/Dr) ________________________________________________________ Surname__________________________________________________________________ Job Title __________________________________________________________________ Nationality ________________________________________________________________ Company _________________________________________________________________ THIS CONTAINS YOUR UNIQUE REGISTRATION REFERENCE PLEASE DO NOT REMOVE MAILING LABEL Address __________________________________________________________________ 1. Registration for CFRP 2008 4. Accommodation ________________________________________________________________________ ❐ Full Fee: US$1,895 per person ❐ Please send me a hotel ❐ Early Bird Fee: US$1,695 per reservation form Country _____________________________Postal/Zip Code__________________________ person (pay by 28 March 2008) ❐ Team Fee: US$1,695 per 5. Sponsorship Information and Tel _________________________________Fax __________________________________ person for second & subsequent Documentation delegate from the same ❐ I would like full details on company & billing address sponsorship Email ____________________________________________________________________ ❐ I can’t attend but I am 2. Registration for Workshop interested to purchase Name and Title of Approving Manager ______________________________________________ ❐ Full Fee: US$600 per person documentation for this event ❐ Team Fee: US$540 per person (post event only) Email of Approving Manager ____________________________________________________ ❐ Joint Attendance Fee: US$540 per person 5. Mailing List Special Dietary Requirements (if any) ______________________________________________ ❐ Please include me in your 3. Payment mailing list for future events. ❐ I am sending payment by Main Business Activity ________________________________________________________ telegraphic transfer/bank draft PAYMENTS MUST BE RECEIVED BEFORE ❐ I will need an original invoice THE CONFERENCE DATE. ________________________________________________________________________ CA225/08 WB

×